Drugs / B10-FC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07156864 | Sep → Dec 2025 overdue | COVID-19 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B10-FC | “Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients” NCT07156864 ↗ |
| Route | Other | “parenteral administration” NCT07156864 ↗ |